Health Care & Life Sciences » Pharmaceuticals | Nanjing Pharmaceutical Co. Ltd.

Nanjing Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
18,714
22,046
24,782
26,685
27,426
31,238
Cost of Goods Sold (COGS) incl. D&A
17,630
20,827
23,432
25,242
25,828
29,357
Gross Income
1,084
1,219
1,350
1,443
1,598
1,881
SG&A Expense
759
796
840
861
935
1,089
EBIT
307
406
494
578
663
792
Unusual Expense
-
39
13
-
24
7
Non Operating Income/Expense
71
67
18
9
82
28
Interest Expense
256
311
247
228
292
360
Pretax Income
115
196
266
352
442
480
Income Tax
61
52
78
101
129
130
Equity in Affiliates
7
8
5
13
2
4
Consolidated Net Income
60
152
193
239
311
346
Net Income
39
129
157
180
239
264
Net Income After Extraordinaries
39
129
157
180
239
264
Net Income Available to Common
39
129
157
180
239
264
EPS (Basic)
0.06
0.14
0.18
0.20
0.27
0.26
Basic Shares Outstanding
694
897
897
897
897
1,017
EPS (Diluted)
0.06
0.14
0.17
0.20
0.27
0.26
Diluted Shares Outstanding
694
897
897
897
897
1,017
EBITDA
409
512
582
674
757
919
Other Operating Expense
18
17
16
4
-
-
Non-Operating Interest Income
28
18
20
10
12
12
Minority Interest Expense
21
24
36
58
72
82

About Nanjing Pharmaceutical Co.

View Profile
Address
Building 8
Nanjing Jiangsu 210002
China
Employees -
Website http://www.njyy.com
Updated 07/08/2019
Nanjing Pharmaceutical Co., Ltd. is engaged in the manufacture and sale of pharmaceutical products. Its other activities include production and distribution of medical treatment equipment, chemical reagent, glass apparatus, chemical-used materials and related products. The company was founded in 1951 and is headquartered in Nanjing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.